Literature DB >> 32334650

Myocarditis in a patient with COVID-19: a cause of raised troponin and ECG changes.

Denis Doyen1, Pamela Moceri2, Dorothée Ducreux3, Jean Dellamonica4.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32334650      PMCID: PMC7180035          DOI: 10.1016/S0140-6736(20)30912-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
A 69-year old man, from Lombardy, Italy, was admitted to our unit because of acute respiratory distress syndrome that required mechanical ventilation; he was in Nice, France, on holiday. He had previously been fit and well; he had a history of hypertension controlled with bisoprolol 2·5 mg/day. He initially reported vomiting and diarrhoea, and 7 days afterwards, he came to our emergency department with a cough, fever of 39°C, and dyspnoea. He was immediately transferred to our intensive care unit (ICU) because of the respiratory distress syndrome and severe hypoxia. Investigations found a haemoglobin concentration of 15·4 g/dL, a platelet count of 187 × 109 per L, and a leucocyte count of 14·9 × 109 per L (neutrophils 89%, lymphocytes 7%, monocytes 4%, and no eosinophils or basophils 0%). His blood pH was 7·27, partial pressure of carbon dioxide was 45·3 mm Hg, partial pressure of oxygen was 146 mm Hg, and peripheral oxygen saturation was 98·2%. A CT of his chest showed bilateral ground-glass opacities and condensations (figure ; video). PCR of swabs taken from his upper respiratory tract showed severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) confirming a diagnosis of coronavirus disease 19 (COVID-19). Multiplex PCR was negative for other viruses using BioFire FilmArray Respiratory Panel 2 plus (bioMérieux, Marcy l'Etoile, France) and no bacterial infections were found. An electrocardiogram (ECG), done on admission to the ICU, showed signs of left ventricular hypertrophy (LVH) and diffuse inverted T waves (figure)—a previous ECG showed inverted T waves in anterior leads only. High-sensitivity cardiac troponin I concentration was raised at 9002 ng/L (normal <40). Transthoracic echocardiography showed mild LVH; the left ventricular ejection fraction and wall motion were within normal limits (figure; video). The patient was known to have LVH which was probably caused by his chronic hypertension.
Figure

Myocarditis and coronavirus disease 19

(A) Chest CT shows bilateral crazy paving pattern, ground-glass opacities and condensations. (B) Electrocardiogram shows diffuse T-wave inversion (arrowheads) and left ventricular hypertrophy. (C) Echocardiogram shows left ventricular hypertrophy (arrowhead). (D) Cardiovascular magnetic resonance—4 chamber view—shows subepicardial late gadolinium enhancement of the apex and inferior wall (arrowheads).

Myocarditis and coronavirus disease 19 (A) Chest CT shows bilateral crazy paving pattern, ground-glass opacities and condensations. (B) Electrocardiogram shows diffuse T-wave inversion (arrowheads) and left ventricular hypertrophy. (C) Echocardiogram shows left ventricular hypertrophy (arrowhead). (D) Cardiovascular magnetic resonance—4 chamber view—shows subepicardial late gadolinium enhancement of the apex and inferior wall (arrowheads). Antiplatelet therapy—aspirin—and anticoagulation therapy—fondaparinux—were started because we suspected a non-ST elevation myocardial infarction: his Global Registry of Acute Coronary Events (GRACE) score was greater than 140. However, coronary angiography showed no disease, but cardiovascular magnetic resonance scanning showed subepicardial late gadolinium enhancement of the apex and inferolateral wall—suggestive of myocarditis (figure; video). We decided not to do an endomyocardial biopsy because the patient showed no signs of heart failure or arrhythmias. Additional tests for common causes of myocarditis—including parvovirus B19, human herpes virus, Epstein-Barr virus, enterovirus, cytomegalovirus, adenovirus, HIV, and hepatitis C virus—were negative. We therefore concluded that SARS-CoV-2 infection was the most likely cause of our patient's myocarditis. We gave the patient hydrocortisone at day 11 for 9 days with the aim of reducing inflammation—particularly of the myocardium. The patient was weaned off mechanical ventilation and discharged from the ICU after 3 weeks. We believe this comprehensive description of myocarditis associated with COVID-19 confirms the importance of recent data reporting acute cardiac injury in almost a fifth of patients, with a 50% survival rate. It is recommended that troponin is not routinely measured in patients with COVID-19. However, physicians need to pay heed to the possibility of myocarditis in cases of COVID-19: in cases with high GRACE scores and dynamic ECG changes, usual guidelines to exclude the possibility of an acute myocardial infarction, including measuring troponin and doing an angiogram within 24 h, need to be followed (video).
  86 in total

1.  A specialised cardiorespiratory team approach in the intensive care management of COVID-19 patients: benefit on mortality, diagnosis and management.

Authors:  Asad Anwar; Nordita Ramos-Bascon; A Agatha Crerar-Gilbert; Natalie Barnes; Brendan Madden
Journal:  Clin Med (Lond)       Date:  2021-03       Impact factor: 2.659

2.  Update of the recommendations of the Sociedade Portuguesa de Cuidados Intensivos and the Infection and Sepsis Group for the approach to COVID-19 in Intensive Care Medicine.

Authors:  João João Mendes; José Artur Paiva; Filipe Gonzalez; Paulo Mergulhão; Filipe Froes; Roberto Roncon; João Gouveia
Journal:  Rev Bras Ter Intensiva       Date:  2022-01-24

3.  Invasive Management of Acute Myocardial Infarctions During the Initial Wave of the COVID-19 Pandemic.

Authors:  Nina Talmor; Abhinay Ramachandran; Shari B Brosnahan; Binita Shah; Sripal Bangalore; Louai Razzouk; Michael Attubato; Frederick Feit; Craig Thompson; Nathaniel R Smilowitz
Journal:  J Invasive Cardiol       Date:  2021-12-05       Impact factor: 2.022

4.  Early echocardiographic findings in patients hospitalized for COVID-19 pneumonia: a prospective, single center study.

Authors:  Elisa Ceriani; Azzurra Marceca; Antonio Lanfranchi; Stefano De Vita; Riccardo Schiavon; Francesco Casella; Daniela Torzillo; Marta Del Medico; Diego Ruggiero; Alberto Barosi; Chiara Cogliati
Journal:  Intern Emerg Med       Date:  2021-05-21       Impact factor: 3.397

Review 5.  Corticosteroid Therapy in Management of Myocarditis Associated with COVID-19; a Systematic Review of Current Evidence.

Authors:  William Kamarullah; Claudia Mary Josephine; Rachmatu Bill Multazam; Aqila Ghaezany Nawing; Surya Dharma
Journal:  Arch Acad Emerg Med       Date:  2021-04-16

6.  International Prospective Registry of Acute Coronary Syndromes in Patients With COVID-19.

Authors:  Thomas A Kite; Peter F Ludman; Chris P Gale; Jianhua Wu; Adriano Caixeta; Jacques Mansourati; Manel Sabate; Pilar Jimenez-Quevedo; Luciano Candilio; Parham Sadeghipour; Angel M Iniesta; Stephen P Hoole; Nick Palmer; Albert Ariza-Solé; Alim Namitokov; Hector H Escutia-Cuevas; Flavien Vincent; Otilia Tica; Mzee Ngunga; Imad Meray; Andrew Morrow; Md Minhaj Arefin; Steven Lindsay; Ghada Kazamel; Vinoda Sharma; Aly Saad; Gianfranco Sinagra; Federico Ariel Sanchez; Marek Roik; Stefano Savonitto; Marija Vavlukis; Shankar Sangaraju; Iqbal S Malik; Sharon Kean; Nick Curzen; Colin Berry; Gregg W Stone; Bernard J Gersh; Anthony H Gershlick
Journal:  J Am Coll Cardiol       Date:  2021-05-25       Impact factor: 24.094

7.  Successful heart transplantation for COVID-19-associated post-infectious fulminant myocarditis.

Authors:  Baptiste Gaudriot; Alexandre Mansour; Vincent Thibault; Mathieu Lederlin; Aurélie Cauchois; Bernard Lelong; James T Ross; Guillaume Leurent; Jean-Marc Tadié; Matthieu Revest; Jean-Philippe Verhoye; Erwan Flecher; Nicolas Nesseler
Journal:  ESC Heart Fail       Date:  2021-05-02

Review 8.  Utility of Non-invasive Cardiac Imaging Assessment in Coronavirus Disease 2019.

Authors:  Sandeep S Hothi; Jin Jiang; Richard P Steeds; William E Moody
Journal:  Front Cardiovasc Med       Date:  2021-05-21

9.  COVID-19 and Cardiomyopathy: A Systematic Review.

Authors:  Fatemeh Omidi; Bahareh Hajikhani; Seyyedeh Neda Kazemi; Ardeshir Tajbakhsh; Sajedeh Riazi; Mehdi Mirsaeidi; Ali Ansari; Masoud Ghanbari Boroujeni; Farima Khalili; Sara Hadadi; Mohammad Javad Nasiri
Journal:  Front Cardiovasc Med       Date:  2021-06-17

Review 10.  SARS-CoV-2 Myocarditis: Insights Into Incidence, Prognosis, and Therapeutic Implications.

Authors:  Ossama K Abou Hassan; Calvin C Sheng; Tom Kai Ming Wang; Paul C Cremer
Journal:  Curr Cardiol Rep       Date:  2021-08-03       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.